(Q36136406)

English

Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

anti-retroviral agent

0 references

7

object named as

A C Collier

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

J D Stekler

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

R Wellman

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

S Holte

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

J Maenza

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

C E Stevens

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

L Corey

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

1 March 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

International Journal of STD & AIDS

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

201-206

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

HIV dynamics in seminal plasma during primary HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

Detection of acute HIV infections in an urban HIV counseling and testing population in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 October 2017

Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 Study Group. Division of AIDS Treatment Research Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

2 July 2018

The effect of antiretroviral treatment of different durations in primary HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Detection of acute HIV infections in high-risk patients in California.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Detection of acute infections during HIV testing in North Carolina.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Initiation of therapy during primary HIV type 1 infection results in a continuous decay of proviral DNA and a highly restricted viral evolution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

A controlled trial of zidovudine in primary human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410712

23 September 2018

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011178

21 January 2018

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011178

21 January 2018

Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011178

21 January 2018

Clinical and epidemiologic features of primary HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary HIV infection: follow-up of patients initially randomized to zidovudine or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological and virologic characteristics of primary HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does transient HAART during primary HIV-1 infection lower the virological set-point?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22581875

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1258/IJSA.2011.011178

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36136406&oldid=1997354393"